Literature DB >> 28473085

ACR Appropriateness Criteria® Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women.

Linda Moy1, Lisa Bailey2, Carl D'Orsi3, Edward D Green4, Anna I Holbrook3, Su-Ju Lee5, Ana P Lourenco6, Martha B Mainiero6, Karla A Sepulveda7, Priscilla J Slanetz8, Sunita Trikha9, Monica M Yepes10, Mary S Newell11.   

Abstract

Women and health care professionals generally prefer intensive follow-up after a diagnosis of breast cancer. However, there are no survival differences between women who obtain intensive surveillance with imaging and laboratory studies compared with women who only undergo testing because of the development of symptoms or findings on clinical examinations. American Society of Clinical Oncology and National Comprehensive Cancer Network guidelines state that annual mammography is the only imaging examination that should be performed to detect a localized breast recurrence in asymptomatic patients; more imaging may be needed if the patient has locoregional symptoms (eg, palpable abnormality). Women with other risk factors that increase their lifetime risk for breast cancer may warrant evaluation with breast MRI. Furthermore, the quality of life is similar for women who undergo intensive surveillance compared with those who do not. There is little justification for imaging to detect or rule out metastasis in asymptomatic women with newly diagnosed stage I breast cancer. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Copyright © 2017 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AUC; Appropriate Use Criteria; Appropriateness Criteria; breast MRI; mammography; metastasis; stage I breast cancer

Mesh:

Year:  2017        PMID: 28473085     DOI: 10.1016/j.jacr.2017.02.009

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  3 in total

1.  Imaging Surveillance After Definitive Treatment for Breast Cancer.

Authors:  Natalia S Partain; Kelly K Hunt
Journal:  Ann Surg Oncol       Date:  2018-09-20       Impact factor: 5.344

2.  PET-CT for Evaluating Breast Cancer Yields Incidental Finding in the Lung.

Authors:  Raquel Perez; Gladys Montane; Jill S Gluskin; Garth Nanni
Journal:  Radiol Technol       Date:  2019-11

Review 3.  Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review.

Authors:  Jeroen Swinnen; Machteld Keupers; Julie Soens; Matthias Lavens; Sandra Postema; Chantal Van Ongeval
Journal:  Insights Imaging       Date:  2018-11-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.